Daniela Rezek

Influence of side-effects on early therapy persistence with letrozole in post-menopausal patients with early breast cancer: Results of the prospective EvAluate-TM study

Naiba Nabieva, Tanja Fehm, Lothar Häberle et al. · European Journal of Cancer · 2018 · 49 citations

Medicine, Oncology, Pharmacology +17

Benchmarking of a checklist for the identification of familial risk for breast and ovarian cancers in a prospective cohort

Kerstin Rhiem, Hans‐Joachim Bücker‐Nott, Martin Hellmich et al. · The Breast Journal · 2019 · 48 citations

Medicine, Genetics, Oncology +17

Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers

Olaf Ortmann, Jens‐Uwe Blohmer, Nora Tabea Sibert et al. · Journal of Cancer Research and Clinical Oncology · 2022 · 48 citations · Full text

Medicine, Oncology, Breast Oncology +12

Influence of patient and tumor characteristics on early therapy persistence with letrozole in postmenopausal women with early breast cancer: results of the prospective Evaluate-TM study with 3941 patients

Naiba Nabieva, S. Kellner, Tanja Fehm et al. · Annals of Oncology · 2017 · 44 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Interest in Integrative Medicine Among Postmenopausal Hormone Receptor–Positive Breast Cancer Patients in the EvAluate-TM Study

Carolin C. Hack, Peter A. Fasching, Tanja Fehm et al. · Integrative Cancer Therapies · 2016 · 28 citations · Full text

Medicine, Endocrinology, Oncology +15